BELITE BIO, INC financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
BLTE on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
31 Mar 2026

Quick Takeaways

  • BLTE - BELITE BIO, INC financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Current Ratio 50.02x.

What Changed

  • Current Ratio YoY change: <span class="text-green-600">+106%</span>.
  • Most recent SEC facts end date: 31 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Current Ratio 50.02x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

4.0/100

Weak Confidence low

Financial Health

Current Ratio
50.02x

Strengths

No strong signals yet.

Watchpoints

Current Ratio

Key metrics snapshot

Current Ratio

50.02x

YoY: +106%

Industry median: 3.39x (n=667)

View history

Financial Health

Metric Latest value YoY change
Current Ratio 50.02x +106%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 39,339,960 +24%
Common Stock, Shares, Outstanding 39,339,960 +24%
Common Stock, Value, Issued $4,000 +33%

Additional Metrics

Metric Latest value YoY change
Cash and Cash Equivalents, at Carrying Value $352,932,000 +1014%
Other Assets, Current $5,000
Assets, Current $494,272,000 +236%
Property, Plant and Equipment, Net $344,000 -23%
Operating Lease, Right-of-Use Asset $433,000 -17%
Intangible Assets, Net (Excluding Goodwill) $19,000 -39%
Assets $780,556,000 +413%
Employee-related Liabilities, Current $1,610,000 +129%
Accrued Liabilities, Current $9,636,000 +67%
Liabilities, Current $9,882,000 +63%
Operating Lease, Liability, Noncurrent $188,000 -28%
Liabilities $10,070,000 +60%
Accumulated Other Comprehensive Income (Loss), Net of Tax $536,000 +19%
Retained Earnings (Accumulated Deficit) $185,258,000 -72%
Stockholders' Equity Attributable to Parent $770,486,000 +428%
Liabilities and Equity $780,556,000 +413%
Common Stock, Shares Authorized 400,000,000 0%
Common Stock, Shares, Issued 39,353,365 +24%
Common Stock, Par or Stated Value Per Share 0.0001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $352,932,000 +1014%
Deferred Tax Assets, Valuation Allowance $20,486,000 +87%
Deferred Tax Assets, Gross $20,486,000 +87%
Operating Lease, Liability $429,000 -20%
Lessee, Operating Lease, Liability, to be Paid $449,000 -20%
Operating Lease, Liability, Current $241,000 -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $151,000 -19%
Lessee, Operating Lease, Liability, to be Paid, Year One $255,000 -12%
Operating Lease, Weighted Average Discount Rate, Percent 0.0485 +32%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20,000 -4.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three $43,000 -46%
Deferred Tax Assets, Operating Loss Carryforwards $17,414,000 +80%
Unrecognized Tax Benefits $0
Additional Paid in Capital $956,276,000 +276%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY